Pareesa Afreen 
Jan 01, 2026
Tech billionaire Elon Musk has revealed that his brain-computer interface startup, Neuralink, will begin high-volume production of brain chip implants and shift to fully automated surgical procedures in 2026.
The achievement was announced by Elon Musk on X (formerly known as Twitter) on Wednesday, highlighting a significant development in integrating technology and healthcare.
The chips developed by Neuralink want to assist people suffering from serious health issues, such as persons suffering from spinal cord injuries. The first human, a paralysed individual, has already used the device to play video games, browse the web, post messages on social media, and operate a cursor on a laptop using their mind.
Neuralink began human trials in 2024, resolving safety issues raised by the US Food and Drug Administration (FDA), which had caused the company to put off an application planned for the following year, 2022. As of September 2025, the first twelve patients worldwide had been implanted, allowing them to control digital and physical operations using only their minds.
The corporation has also strengthened its financial position by raising £650 million in June in a funding round, which reflects immense confidence in its plans.
